| UniProt ID | EPN3_HUMAN | |
|---|---|---|
| UniProt AC | Q9H201 | |
| Protein Name | Epsin-3 | |
| Gene Name | EPN3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 632 | |
| Subcellular Localization | Cytoplasm . Cytoplasm, perinuclear region . Cytoplasmic vesicle, clathrin-coated vesicle . Nucleus . Concentrated in the perinuclear region and associated with clathrin-coated vesicles close to the cell periphery. May shuttle to the nucleus. | |
| Protein Description | ||
| Protein Sequence | MTTSALRRQVKNIVHNYSEAEIKVREATSNDPWGPPSSLMSEIADLTFNTVAFTEVMGMLWRRLNDSGKNWRHVYKALTLLDYLLKTGSERVAHQCRENLYTIQTLKDFQYIDRDGKDQGVNVREKVKQVMALLKDEERLRQERTHALKTKERMALEGIGIGSGQLGFSRRYGEDYSRSRGSPSSYNSSSSSPRYTSDLEQARPQTSGEEELQLQLALAMSREEAEKPVPPASHRDEDLQLQLALRLSRQEHEKEVRSWQGDGSPMANGAGAVVHHQRDREPEREERKEEEKLKTSQSSILDLADIFVPALAPPSTHCSADPWDIPGFRPNTEASGSSWGPSADPWSPIPSGTVLSRSQPWDLTPMLSSSEPWGRTPVLPAGPPTTDPWALNSPHHKLPSTGADPWGASLETSDTPGGASTFDPFAKPPESTETKEGLEQALPSGKPSSPVELDLFGDPSPSSKQNGTKEPDALDLGILGEALTQPSKEARACRTPESFLGPSASSLVNLDSLVKAPQVAKTRNPFLTGLSAPSPTNPFGAGEPGRPTLNQMRTGSPALGLAGGPVGAPLGSMTYSASLPLPLSSVPAGLTLPASVSVFPQAGAFAPQPLLPTPSSAGPRPPPPQTGTNPFL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MTTSALRRQ ------CCHHHHHHH | 29.47 | 29116813 | |
| 3 | Phosphorylation | -----MTTSALRRQV -----CCHHHHHHHH | 15.65 | 23836654 | |
| 4 | Phosphorylation | ----MTTSALRRQVK ----CCHHHHHHHHH | 19.01 | 29116813 | |
| 17 | Phosphorylation | VKNIVHNYSEAEIKV HHHHHHCCCHHEEEE | 7.94 | 28152594 | |
| 18 | Phosphorylation | KNIVHNYSEAEIKVR HHHHHCCCHHEEEEE | 35.33 | 28152594 | |
| 23 (in isoform 1) | Ubiquitination | - | 27.09 | 21890473 | |
| 23 | Ubiquitination | NYSEAEIKVREATSN CCCHHEEEEEECCCC | 27.09 | 21890473 | |
| 23 (in isoform 2) | Ubiquitination | - | 27.09 | 21890473 | |
| 47 | Phosphorylation | MSEIADLTFNTVAFT HHHHHHCCHHHHHHH | 18.52 | 30257219 | |
| 75 | Phosphorylation | GKNWRHVYKALTLLD CCCHHHHHHHHHHHH | 5.61 | 18083107 | |
| 83 | Phosphorylation | KALTLLDYLLKTGSE HHHHHHHHHHHHCCH | 17.57 | 22817900 | |
| 101 | Phosphorylation | HQCRENLYTIQTLKD HHHHHCCEEEEECCC | 17.24 | - | |
| 102 | Phosphorylation | QCRENLYTIQTLKDF HHHHCCEEEEECCCC | 15.13 | - | |
| 111 | Phosphorylation | QTLKDFQYIDRDGKD EECCCCCEECCCCCC | 12.55 | 29978859 | |
| 117 | Ubiquitination | QYIDRDGKDQGVNVR CEECCCCCCCCCCHH | 51.68 | 29901268 | |
| 117 (in isoform 1) | Ubiquitination | - | 51.68 | 21890473 | |
| 117 (in isoform 2) | Ubiquitination | - | 51.68 | 21890473 | |
| 149 | Ubiquitination | QERTHALKTKERMAL HHHHHHHHHHHHHHH | 59.33 | - | |
| 163 | Phosphorylation | LEGIGIGSGQLGFSR HCCCCCCCCCCCCCC | 22.80 | 24719451 | |
| 169 | Phosphorylation | GSGQLGFSRRYGEDY CCCCCCCCCHHCCCC | 17.66 | 24719451 | |
| 172 | Phosphorylation | QLGFSRRYGEDYSRS CCCCCCHHCCCCCCC | 24.61 | 24927040 | |
| 176 | Phosphorylation | SRRYGEDYSRSRGSP CCHHCCCCCCCCCCC | 11.15 | 28152594 | |
| 177 | Phosphorylation | RRYGEDYSRSRGSPS CHHCCCCCCCCCCCC | 35.78 | 28152594 | |
| 179 | Phosphorylation | YGEDYSRSRGSPSSY HCCCCCCCCCCCCCC | 34.74 | 23090842 | |
| 182 | Phosphorylation | DYSRSRGSPSSYNSS CCCCCCCCCCCCCCC | 22.09 | 25849741 | |
| 184 | Phosphorylation | SRSRGSPSSYNSSSS CCCCCCCCCCCCCCC | 47.34 | 33259812 | |
| 185 | Phosphorylation | RSRGSPSSYNSSSSS CCCCCCCCCCCCCCC | 31.55 | 23090842 | |
| 186 | Phosphorylation | SRGSPSSYNSSSSSP CCCCCCCCCCCCCCC | 24.33 | 19534553 | |
| 188 | Phosphorylation | GSPSSYNSSSSSPRY CCCCCCCCCCCCCCC | 24.30 | 23090842 | |
| 189 | Phosphorylation | SPSSYNSSSSSPRYT CCCCCCCCCCCCCCC | 30.51 | 23090842 | |
| 190 | Phosphorylation | PSSYNSSSSSPRYTS CCCCCCCCCCCCCCC | 34.36 | 23090842 | |
| 191 | Phosphorylation | SSYNSSSSSPRYTSD CCCCCCCCCCCCCCC | 46.43 | 25849741 | |
| 192 | Phosphorylation | SYNSSSSSPRYTSDL CCCCCCCCCCCCCCH | 18.49 | 28985074 | |
| 195 | Phosphorylation | SSSSSPRYTSDLEQA CCCCCCCCCCCHHHH | 17.61 | 22817900 | |
| 206 | Phosphorylation | LEQARPQTSGEEELQ HHHHCCCCCCHHHHH | 41.19 | - | |
| 207 | Phosphorylation | EQARPQTSGEEELQL HHHCCCCCCHHHHHH | 38.67 | - | |
| 258 | Phosphorylation | EHEKEVRSWQGDGSP HHHHHHHHCCCCCCC | 29.00 | 27794612 | |
| 264 | Phosphorylation | RSWQGDGSPMANGAG HHCCCCCCCCCCCCC | 19.08 | 25849741 | |
| 358 | Phosphorylation | SGTVLSRSQPWDLTP CCCEEECCCCCCCCC | 36.90 | 28102081 | |
| 364 | Phosphorylation | RSQPWDLTPMLSSSE CCCCCCCCCCCCCCC | 12.27 | 28102081 | |
| 368 | Phosphorylation | WDLTPMLSSSEPWGR CCCCCCCCCCCCCCC | 26.09 | 28348404 | |
| 385 | Phosphorylation | VLPAGPPTTDPWALN CCCCCCCCCCCCHHC | 47.14 | 23312004 | |
| 386 | Phosphorylation | LPAGPPTTDPWALNS CCCCCCCCCCCHHCC | 45.93 | 23312004 | |
| 393 | Phosphorylation | TDPWALNSPHHKLPS CCCCHHCCCCCCCCC | 26.85 | 25849741 | |
| 409 | Phosphorylation | GADPWGASLETSDTP CCCCCCCCCCCCCCC | 23.85 | 27251275 | |
| 412 | Phosphorylation | PWGASLETSDTPGGA CCCCCCCCCCCCCCC | 36.88 | 27251275 | |
| 413 | Phosphorylation | WGASLETSDTPGGAS CCCCCCCCCCCCCCC | 30.06 | 27251275 | |
| 444 | Phosphorylation | GLEQALPSGKPSSPV HHHHHCCCCCCCCCE | 61.37 | 28857561 | |
| 448 | Phosphorylation | ALPSGKPSSPVELDL HCCCCCCCCCEEEEC | 51.24 | 25849741 | |
| 449 | Phosphorylation | LPSGKPSSPVELDLF CCCCCCCCCEEEECC | 41.30 | 30278072 | |
| 460 | Phosphorylation | LDLFGDPSPSSKQNG EECCCCCCCCCCCCC | 42.00 | 25849741 | |
| 462 | Phosphorylation | LFGDPSPSSKQNGTK CCCCCCCCCCCCCCC | 55.28 | 30278072 | |
| 463 | Phosphorylation | FGDPSPSSKQNGTKE CCCCCCCCCCCCCCC | 41.46 | 30278072 | |
| 495 | Phosphorylation | KEARACRTPESFLGP HHHHHCCCCHHHHCC | 31.15 | 30278072 | |
| 498 | Phosphorylation | RACRTPESFLGPSAS HHCCCCHHHHCCCHH | 27.29 | 30278072 | |
| 503 | Phosphorylation | PESFLGPSASSLVNL CHHHHCCCHHHHCCH | 38.70 | 26657352 | |
| 505 | Phosphorylation | SFLGPSASSLVNLDS HHHCCCHHHHCCHHH | 28.66 | 26657352 | |
| 506 | Phosphorylation | FLGPSASSLVNLDSL HHCCCHHHHCCHHHH | 35.73 | 27542207 | |
| 522 | Phosphorylation | KAPQVAKTRNPFLTG CCCHHHCCCCCCCCC | 26.41 | 28102081 | |
| 528 | Phosphorylation | KTRNPFLTGLSAPSP CCCCCCCCCCCCCCC | 36.13 | 28348404 | |
| 531 | Phosphorylation | NPFLTGLSAPSPTNP CCCCCCCCCCCCCCC | 39.21 | 28348404 | |
| 534 | Phosphorylation | LTGLSAPSPTNPFGA CCCCCCCCCCCCCCC | 44.03 | 28102081 | |
| 536 | Phosphorylation | GLSAPSPTNPFGAGE CCCCCCCCCCCCCCC | 60.92 | 28102081 | |
| 613 | Phosphorylation | APQPLLPTPSSAGPR CCCCCCCCCCCCCCC | 35.45 | 26853621 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EPN3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EPN3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPN3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-17; TYR-176 AND TYR-186,AND MASS SPECTROMETRY. | |